ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,396,957, issued on Aug. 26.
"Cell lines and their use in encapsulated cell biodelivery" was invented by Philip Kusk (Lynge, Denmark) and Lars Ulrik Wahlberg (Bristol, R.I.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to generation of cell lines expressing recombinant proteins for use in naked and encapsulated cell biodelivery of secreted therapeutic molecules. In one embodiment the cell line is human. In another aspect of the invention the transposon system is used for generating a cell line for secretion of a biologically active polypeptide."
The patent was filed on Jan. 11, 2021, under Application No. 17/145,877.
*For...